Statements: Chemo Group

Canonical ID: ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 · Entity type: Company (reference)

This table shows statement-based, sourced records from our database. For more context, learn about how OpenSanctions stores information.

Property		Value	Lang	Source dataset		Source ID	First seen
`Company:notes`		"Iranian media reported in March 2016 that Barakat Pharmed had signed a $15 million deal for Spain-based pharmaceutical company Chemo Group to buy a 65 percent stake in a Barakat subsidiary. A 2016 Barakat annual report states that 65 percent of shares of Ati Pharmed, previously owned by Barakat and Alborz Investment Group, a Barakat subsidiary, were transferred to Chemo. A person familiar with Ati Pharmed affairs confirmed the transfer. Chemo officials did not respond to requests for comment." (Reuters, "Post-Sanctions Deals with Iranian Firms Linked to Khamenei," 1/19/2017). (http://www.dailymail.co.uk/wires/reuters/article-4136746/Post-sanctions-deals-Iranian-firms-linked-Khamenei.html)		ir_uani_business_registry		`ir-br-co-6255e6de5391ed201369804ec44016faa2a28905`	2025-10-10